HUMAN-LIKE CANCER TISSUE MODELS AS A DRUG SCREENING PLATFORM
VoxCell BioInnovation is developing human-like cancer tissue models as drug screening platforms.These tissues are created by our proprietary technology: Canada's first high-resolution bioprinter, trade-secret vascularization software, and Universal Bioinks (Figure 1).VoxCell's 3D bioprinter offers 600x higher resolution than currently adopted bioprinting technologies using the two-photon polymerization process along with high accuracy and precision beam steering and motion control.
Authors
- Geneviève N. Boice (ORCID: https://orcid.org/0000-0002-3083-6162)
- Asees Kaur
- Annette Poon
- Anne-Karine Lapointe
- Samuel Steiner
- Karolina Papera Valente (ORCID: https://orcid.org/0000-0003-4847-7345)
- Sam Paton
- Ekaterina Shteinberg
- Jenna Sonmor
Publication Details
- Published
- 2024-10-07
- DOI
- https://doi.org/10.70477/lntm6092
- Primary Topic
- 3D Printing in Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00